sulopenem (Pending FDA Approval)

Brand and Other Names:

Dosing & Uses

Urinary Tract Infection

Pending FDA approval for IV treatment of urinary tract infections in patients with a quinolone-resistant pathogen

Next:

Pharmacology

Mechanism of Action

IV sulopenem is a thiopenem with broad-spectrum antibacterial activity against most gram-positive and gram-negative bacteria

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.